transparency
Clinical trials transparency: the journey so far
May 12, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency
There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …
EMA transparency agenda sees more delay
April 9, 2014Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency
The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …
EU votes for trial transparency
April 3, 2014Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott
Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …
AstraZeneca opens up research
March 28, 2014Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website
AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …
Data transparency debate: Europe decides its future
March 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency
Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …
Novartis extends trial transparency
February 27, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency
Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.
J&J reveals more on transparency policy
February 3, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda
Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …
NHS patient data to be shared with researchers
January 6, 2014Medical Communications, Research and Development, Sales and Marketing NHS, data, online, transparency
NHS England will begin to gather patient data from GPs for the first time this spring to ‘improve care and …
GSK and Sanofi expand transparency
January 6, 2014Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency
GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …
Europe to vote on greater trial transparency
December 17, 2013Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency
Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …
GSK changes sales tactics
December 17, 2013Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency
GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products. The UK …
Court annuls EMA data decision
December 5, 2013Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency
The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
